Flu jab cuts CV risk and death in type 2 diabetes
In Clinical
Follow this topic
Bookmark
Record learning outcomes
An analysis of primary and secondary care data collected in England shows that influenza vaccination seems to cut mortality by almost a quarter and reduce cardiovascular admissions among people with type 2 diabetes.
The study analysed data collected between 2003/04 and 2009/10 from 124,503 adults with type 2 diabetes. People who received influenza vaccines were older and had more co-morbidities than non-recipients, which reflects current policy.
During the influenza seasons, compared to non-recipients and after adjusting for confounders, flu vaccination was associated with:
• A 30 per cent reduction in hospital admissions for stroke
• A 22 per cent reduction in admissions for heart failure
• A 15 per cent reduction in admissions for pneumonia or influenza.
Influenza vaccination was also associated with a 24 per cent reduction in all-cause mortality during the influenza seasons. A 19 per cent reduction in admissions for acute myocardial infarction was not statistically significant. Excluding the 2008/9 pandemic swine flu season did not markedly alter the results.
“These findings underline the importance of influenza vaccination as part of comprehensive secondary prevention in this high-risk population,†the authors comment.
CMAJ DOI:10.1503/cmaj.151059